Category: Antibody Technologies
Antibody Technologies market research reports by DelveInsight
-
Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030
Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030 Cancer Monoclonal Antibodies Market by Type (Humanized Antibodies, Chimeric Antibodies, Murine Antibodies), Application (Blood Cancer, Breast Cancer, Liver Cancer, Colorectal Cancer, and Others), End-Us ... Read More
-
Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030
Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 Plasma Protein Therapeutics Market by Product (Immunoglobulin, Albumin, Plasma Derived Factor VIII, and Others), Application (Hemophilia, Idiopathic Thrombocytopenic, Primary Immunodeficiencies, and Othe ... Read More
-
Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034
Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Myasthenia Gravis market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of Myasthenia gravis in the 7MM is expected to increase, driven by the launch ... Read More
-
Antibody Drug Conjugate - Market Insights, Competitive Landscape, and Market Forecast - 2030
Antibody Drug Conjugate - Market Insights, Competitive Landscape, and Market Forecast - 2030 Antibody Drug Conjugate Market By Cancer Type (Breast Cancer, Lung Cancer, Bladder Cancer, Brain Tumor, And Others), Target Type (CD19, HER2, CD22, And Others), End-User (Hospitals And Specialty Cancer Cente ... Read More
-
Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030
Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030 Biopharmaceuticals Contract Manufacturing Market by Product (Biologics [Monoclonal Antibodies (MABs), Proteins/Peptides, Vaccines, and Others], Biosimilar), Source (Mammalian and Non-Mammal ... Read More
-
Intravenous Immunoglobulin – Market Insight, Epidemiology, and Market Forecast – 2034
Intravenous Immunoglobulin – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Intravenous Immunoglobulin – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Intravenous Immunoglobulin, historical and forecasted epide ... Read More
-
Antibody-Mediated Graft Rejection – Market Insight, Epidemiology, and Market Forecast – 2034
Antibody-Mediated Graft Rejection – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Antibody-Mediated Graft Rejection – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Antibody-Mediated Graft Rejection, historical ... Read More
-
Anti-CD80 Antibody - Pipeline Insight, 2024
Anti-CD80 Antibody - Pipeline Insight, 2024 “Anti-CD80 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD80 Antibody development. The report provides detailed coverage o ... Read More
-
Antibody-Mediated Graft Rejection - Pipeline Insight, 2024
Antibody-Mediated Graft Rejection - Pipeline Insight, 2024 Antibody-Mediated Graft Rejection Overview ""Antibody-Mediated Graft Rejection Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Antibody-M ... Read More
-
Anti-CD37 Antibody - Pipeline Insight, 2024
Anti-CD37 Antibody - Pipeline Insight, 2024 “Anti-CD37 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024 “Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Dickkopf-1 (Dkk-1) Antibody developmen ... Read More
-
Anti-CD152 Antibody - Pipeline Insight, 2024
Anti-CD152 Antibody - Pipeline Insight, 2024 “Anti-CD152 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD152 Antibody development. The report provides detailed coverag ... Read More
-
Anti GM-CSF Antibody - Pipeline Insight, 2024
Anti GM-CSF Antibody - Pipeline Insight, 2024 “Anti GM-CSF Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti GM-CSF Antibody development. The report provides detailed cove ... Read More
-
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024 “Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The repor ... Read More
-
Anti-CD19 Antibody - Pipeline Insight, 2024
Anti-CD19 Antibody - Pipeline Insight, 2024 “Anti-CD19 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD19 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024 “Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD274 (PD-L1) Antibody development. The report p ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2024
Anti-CD52 Antibody - Pipeline Insight, 2024 “Anti-CD52 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-CD3 Antibody - Pipeline Insight, 2024
Anti-CD3 Antibody - Pipeline Insight, 2024 “Anti-CD3 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of t ... Read More
-
Anti-CD33 Antibody - Pipeline Insight, 2024
Anti-CD33 Antibody - Pipeline Insight, 2024 “Anti-CD33 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-CD28 Antibody - Pipeline Insight, 2024
Anti-CD28 Antibody - Pipeline Insight, 2024 “Anti-CD28 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD28 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-CD38 antibody- Pipeline Insight, 2023
Anti-CD38 antibody- Pipeline Insight, 2023 DelveInsight’s, “Anti-CD38 antibody- Pipeline Insight, 2023” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Anti-CD38 antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More
-
Antibody Drug Conjugate- Competitive landscape, 2023
Antibody Drug Conjugate- Competitive landscape, 2023 DelveInsight’s, “Antibody Drug Conjugate- Competitive landscape, 2023,” report provides comprehensive insights about 180+ companies and 290+ drugs in Antibody Drug Conjugate Competitive landscape. It covers the therapeutics assessment by product t ... Read More
-
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Market Insight, Epidemiology And Market Forecast - 2032
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Anti-neutrophilic cytoplasmic antibody (ANCA) associated vasculitis is a heterogeneous group of rare autoimmune conditions. ANCA Associated Vasculitis includes three ma ... Read More
-
Monoclonal antibodies - Competitive landscape, 2023
Monoclonal antibodies - Competitive landscape, 2023 DelveInsight’s, “Monoclonal antibodies - Competitive landscape, 2023,” report provides comprehensive insights about 180+ companies and 230+ drugs in Monoclonal antibodies Competitive landscape. It covers the therapeutics assessment by product type ... Read More
-
Bispecific antibody - Competitive landscape, 2023
Bispecific antibody - Competitive landscape, 2023 DelveInsight’s, “Bispecific antibody - Competitive landscape, 2023,” report provides comprehensive insights about 250+ companies and 300+ drugs in Bispecific antibody Competitive landscape. It covers the therapeutics assessment by product type, stage ... Read More
Research Assistance
